Breast Cancer Perspective

• Calling Out the FDA's 'We Don't Regulate Medicine' Mantra Dr Vinay Prasad calls the FDA to task over the differing standards the agency uses to grant drug approvals and expanded indications.
  Medscape Oncology, May 2018
• Hormone Therapy and Risk for Cancer in BRCA1 Mutation Carriers   Dr Andrew Kaunitz discusses the impact of hormone therapy on risk for breast cancer in BRCA carriers undergoing risk-reduction surgery.
  Medscape Ob/Gyn, May 2018
• Cardio-oncology Not Just for Subspecialists   Dr Walton-Shirley leads a discussion with Drs Barac and Mehta on what cardio-oncology encompasses today and why many specialties even primary care should take note.
  theheart.org on Medscape, May 2018
• Next-Gen Sequencing at Diagnosis for Patients With Lung Cancer   Dr Mark Kris discusses next-gen sequencing as part of the routine care for patients with lung cancer, underscoring the importance of testing at diagnosis to facilitate appropriate, targeted treatment.
  Medscape Oncology, May 2018
• Palliative Care Questions to Ask Every Advanced Cancer Patient Tips on making palliative care discussions a routine part of advanced breast cancer treatment.
  Medscape Oncology, April 2018
• 'Clear Role' for PARP Inhibitors in Advanced Ovarian Cancer   Recent approval of rucaparib gives patients with ovarian cancer another new option for maintenance therapy.
  Medscape Oncology, April 2018
• ctDNA Shows Wide-Ranging Promise in Breast Cancer From breast cancer screening to detecting minimal residual disease after treatment, circulating tumor DNA testing has many promising applications in breast cancer management.
  Medscape Oncology, April 2018
• A 47-Year-Old Woman With a Swollen Left Leg: USMLE Question A 47-year-old woman presents with a swollen left leg. What risk factor is the most likely cause of her symptoms?
  Osmosis, March 2018
• Practical Ways to Incorporate Acupuncture Into Clinical Practice With evidence of acupuncture's effectiveness mounting, experts outline practical ways to incorporate this complementary treatment into clinical practice.
  Medscape Oncology, March 2018
• 'You Don't Always Need to Do More': De-escalating Breast Cancer Therapy Patients diagnosed with breast cancer could soon be benefiting from what could be described as the next step in personalized therapy: de-escalation of treatment to minimize adverse effects.
  Medscape Oncology, March 2018
• A Surgical Treatment Decision Aid for Breast Cancer Patients Dr Lowenfels comments on a study that examines the effects of a Web-based decision aid versus standard websites in informing women of their options for breast cancer surgery.
  Medscape General Surgery, March 2018
• Listen Carefully During the Medical Interview   In this month's Critical Issues in Primary Care, Dr Fabrizia Faustinella describes two cases where critical listening during the patient history revealed 'red flags' that had been previously missed.
  Medscape Family Medicine, March 2018
• Intermittent Versus Continuous Extended Adjuvant Letrozole A new study supports the approach of 'pausing' letrozole treatment for patients whose previous adjuvant therapy included an aromatase inhibitor, argues Lidia Schapira.
  Medscape Oncology, March 2018
• 'False Hope' Over Immunotherapy? The Media's Misguided Effects   Dr Kathy Miller responds to a recent New York Times article documenting rare immunotherapy responses, which may lead to false hope among cancer patients and their families.
  Medscape Oncology, March 2018
• 'Moving the Needle' in Oncology Workforce Diversity   Authors of a recent ASCO statement on diversity discuss their experiences and suggestions for improving inclusivity in the oncology workforce.
  Medscape Oncology, February 2018
• Beyond APHINITY: What Now After Pivotal Breast Cancer Trial?   Dr Kathy Miller speaks with APHINITY's principal investigator about whether survival in HER2+ disease can be pushed even further.
  Medscape Oncology, February 2018
• Why Do Physicians Overtreat Elderly Breast Cancer Patients?   Drs Kathy Miller and Reshma Jagsi on the reasons behind practitioners' reluctance to omit radiation therapy in older patients.
  Medscape Oncology, February 2018
• 'Cultural Change' in DCIS   Some think it's time to change how we talk about DCIS and to consider de-escalation of therapy. Drs Kathy Miller and Shelley Hwang discuss these hot topics and the COMET study at SABCS 2017.
  Medscape Oncology, January 2018
• Late Recurrence in ER- Positive Breast Cancer: Banking on Biomarkers   Evaluation of biomarkers after 5 years of standard therapy for hormone-positive breast cancer may help determine those at risk for recurrence and those who may need further endocrine therapy.
  Medscape Oncology, January 2018
• Eric Topol's Top 10 Tech Advances Shaping Medicine Dr Eric Topol identifies the latest tech advances in medicine that set the stage for the coming year.
  Medscape, January 2018